外周插入中心导管市场 - 按产品、管腔、应用、最终用途和预测，2024 年 - 2032 年

由于癌症、糖尿病和心血管疾病等慢性疾病盛行率上升，需要长时间服用药物和液体，週边插入中心导管市场规模预计在 2024 年至 2032 年期间复合年增长率为 9.6%。根据世界卫生组织的数据，2022 年将通报约 2,000 万新发癌症病例，导致 970 万人死亡。週边插入中心静脉导管 (PICC) 是传统中心静脉导管的可靠且侵入性较小的替代方案，可为患者提供数週至数月的延长血管通路。这使得它们在医院和门诊中得到广泛采用，促进化疗、肠外营养和抗生素等疗法的实施。

用于精确放置的抗菌涂层和不透射线材料以及整合冲洗系统等创新正在改善感染控制、成像下的可视性以及整体导管管理。微创手术和门诊护理模式的转变也支持了 PICC 的采用，因为与传统中心静脉导管相比，它们可降低併发症发生率并缩短住院时间。

週边插入中心导管产业分为产品、管腔、应用、最终用途和区域。

从产品来看，传统人保财险业务的市场规模预计将在2024 年至2032 年期间产生可观的收入，因为其在安全性、可靠性和医疗保健提供者之间的熟悉度方面有着良好的记录。传统 PICC 因其在提供长期静脉治疗方面的多功能性而广泛用于临床环境，同时最大限度地降低与更具侵入性的中心静脉导管相关的风险。这些设备还配备有利于精确放置、易于维护以及与多种药物和治疗相容的功能。

就最终用途而言，PICC 家庭护理市场市场将在预测期内出现可观的成长。这是因为强烈需要为患者提供一种方便且具有成本效益的选择，以便在传统医院环境之外接受长期静脉治疗。 PICC 还提供了一种可靠的方法，可将药物、液体和肠外营养直接注入中心静脉，从而为需要在家长期治疗的慢性病患者提供支持。

到2032 年，亚太地区外周插入中心导管行业规模将大幅增长。营养的管理。亚太地区国家不断增长的老年人口，加上优先考虑患者舒适度和成本效益的医疗保健政策的转变，将进一步促进市场扩张。

目录

第 1 章：方法与范围

第 2 章：执行摘要

第 3 章：产业洞察

• 产业生态系统分析
• 产业影响力
  • 成长动力
    • 传染病流行率不断上升
    • 慢性病盛行率上升：
    • 技术进步
    • 医疗保健支出增加以及对 PICC 的偏好增加
  • 产业陷阱与挑战
    • 导管相关血流感染 (CRBSI) 的高风险
    • 设备故障
• 成长潜力分析
• 监管环境
• 报销场景
• 技术景观
• 波特的分析
• PESTEL分析
• 未来市场趋势

第 4 章：竞争格局

• 介绍
• 公司矩阵分析
• 公司市占率分析
• 竞争定位矩阵
• 战略仪表板

第 5 章：市场估计与预测：按产品分类，2021 - 2032 年

• 主要趋势
• 电源注入PICC
• 传统PICC
• 新生儿週边静脉导管

第 6 章：市场估计与预测：按 Lumen，2021 - 2032 年

• 主要趋势
• 单身的
• 双倍的
• 多种的

第 7 章：市场估计与预测：按应用分类，2021 - 2032

• 主要趋势
• 化疗
• 长期静脉输注
• 肠外营养
• 输血
• 其他应用

第 8 章：市场估计与预测：按最终用途，2021 - 2032 年

• 主要趋势
• 医院
• 门诊手术中心
• 家庭护理设置
• 其他最终用户

第 9 章：市场估计与预测：按地区，2021 - 2032

• 主要趋势
• 北美洲
  • 我们
  • 加拿大
• 欧洲
  • 德国
  • 英国
  • 法国
  • 义大利
  • 西班牙
  • 荷兰
  • 欧洲其他地区
• 亚太地区
  • 中国
  • 日本
  • 印度
  • 澳洲
  • 韩国
  • 亚太地区其他地区
• 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 拉丁美洲其他地区
• 中东和非洲
  • 沙乌地阿拉伯
  • 南非
  • 阿联酋
  • 中东和非洲其他地区

第 10 章：公司简介

• Access Vascular, Inc.
• AngioDynamic, Inc.
• Argon Medical
• B. Braun Medical Ltd
• Becton, Dickinson and Company
• Biowy Corporation
• Cardinal Health, Inc.
• Footprint Medical Incorporated
• ICU Medical, Inc.
• Kimal Plc
• Medi-Tech Devices
• Teleflex Incorporated

Peripherally inserted central catheters market size is set to register 9.6% CAGR during 2024-2032, driven by the rising prevalence of chronic diseases, such as cancer, diabetes, and cardiovascular conditions, which require prolonged administration of medications and fluids. As per WHO, in 2022, approximately 20 million new cancer cases were reported, resulting in 9.7 million mortalities. Peripherally inserted central catheters (PICCs) offer a reliable and less invasive alternative to traditional central venous catheters for providing patients with extended vascular access for weeks to months. This has led to their widespread adoption in hospitals and outpatient settings, where they facilitate the delivery of chemotherapy, parenteral nutrition, and antibiotics, among other therapies.

Innovations, such as antimicrobial coatings and radiopaque materials for accurate placement, and integrated flushing systems are improving infection control, visibility under imaging, and overall catheter management. The shift towards minimally invasive procedures and outpatient care models is also supporting the adoption of PICCs as they offer reduced complication rates and shorter hospital stays compared to traditional central lines.

The peripherally inserted central catheters industry is divided into product, lumen, application, end-use and region.

Based on product, the market size from the conventional PICC segment is poised to generate substantial revenue during 2024-2032 due to its established track record of safety, reliability, and familiarity among healthcare providers. Conventional PICCs are widely used in clinical settings for their versatility in delivering long-term intravenous therapies while minimizing the risks associated with more invasive central venous catheters. These devices are also equipped with features that facilitate precise placement, ease of maintenance, and compatibility with a wide range of medications and treatments.

Concerning end-use, the PICC market from the home-care settings segment is set to witness decent growth over the forecast period. This is backed by the strong need for offering patients a convenient and cost-effective option for receiving long-term intravenous therapy outside of traditional hospital settings. PICCs also provide a reliable method for administering medications, fluids, and parenteral nutrition directly into a central vein, thereby supporting patients with chronic conditions who require prolonged treatment at home.

Asia Pacific peripherally inserted central catheters industry size will surge significantly through 2032. Advancements in healthcare infrastructure and rising healthcare expenditure in the region are supporting the adoption of PICCs in hospitals and outpatient settings, where they facilitate the administration of chemotherapy, antibiotics, and parenteral nutrition. The growing elderly population in APAC countries, coupled with shifting healthcare policies that prioritize patient comfort and cost-efficiency, will further contribute to the market expansion.

Table of Contents

Chapter 1 Methodology & Scope

• 1.1 Market scope & definitions
• 1.2 Research design
  • 1.2.1 Research approach
  • 1.2.2 Data collection methods
• 1.3 Base estimates & calculations
  • 1.3.1 Base year calculation
  • 1.3.2 Key trends for market estimation
• 1.4 Forecast model
• 1.5 Primary research and validation
  • 1.5.1 Primary sources
  • 1.5.2 Data mining sources

Chapter 2 Executive Summary

• 2.1 Industry 360° synopsis

Chapter 3 Industry Insights

• 3.1 Industry ecosystem analysis
• 3.2 Industry impact forces
  • 3.2.1 Growth drivers
    • 3.2.1.1 Increasing prevalence of infectious diseases
    • 3.2.1.2 Rising prevalence of chronic conditions:
    • 3.2.1.3 Technological advancements
    • 3.2.1.4 Increasing healthcare expenditure and preference for PICCs
  • 3.2.2 Industry pitfalls & challenges
    • 3.2.2.1 High risk of catheter-related bloodstream infections (CRBSI)
    • 3.2.2.2 Malfunctioning of the device
• 3.3 Growth potential analysis
• 3.4 Regulatory landscape
• 3.5 Reimbursement scenario
• 3.6 Technological landscape
• 3.7 Porter's analysis
• 3.8 PESTEL analysis
• 3.9 Future market trends

Chapter 4 Competitive Landscape, 2023

• 4.1 Introduction
• 4.2 Company matrix analysis
• 4.3 Company market share analysis
• 4.4 Competitive positioning matrix
• 4.5 Strategy dashboard

Chapter 5 Market Estimates and Forecast, By Product, 2021 - 2032 ($ Mn)

• 5.1 Key trends
• 5.2 Power injected PICC
• 5.3 Conventional PICC
• 5.4 Neonatal PICC

Chapter 6 Market Estimates and Forecast, By Lumen, 2021 - 2032 ($ Mn)

• 6.1 Key trends
• 6.2 Single
• 6.3 Double
• 6.4 Multiple

Chapter 7 Market Estimates and Forecast, By Application, 2021 - 2032 ($ Mn)

• 7.1 Key trends
• 7.2 Chemotherapy
• 7.3 Long-term IV infusion
• 7.4 Parenteral nutrition
• 7.5 Blood transfusion
• 7.6 Other applications

Chapter 8 Market Estimates and Forecast, By End-use, 2021 - 2032 ($ Mn)

• 8.1 Key trends
• 8.2 Hospitals
• 8.3 Ambulatory surgical centers
• 8.4 Homecare settings
• 8.5 Other end-users

Chapter 9 Market Estimates and Forecast, By Region, 2021 - 2032 ($ Mn)

• 9.1 Key trends
• 9.2 North America
  • 9.2.1 U.S.
  • 9.2.2 Canada
• 9.3 Europe
  • 9.3.1 Germany
  • 9.3.2 UK
  • 9.3.3 France
  • 9.3.4 Italy
  • 9.3.5 Spain
  • 9.3.6 Netherlands
  • 9.3.7 Rest of Europe
• 9.4 Asia Pacific
  • 9.4.1 China
  • 9.4.2 Japan
  • 9.4.3 India
  • 9.4.4 Australia
  • 9.4.5 South Korea
  • 9.4.6 Rest of Asia Pacific
• 9.5 Latin America
  • 9.5.1 Brazil
  • 9.5.2 Mexico
  • 9.5.3 Argentina
  • 9.5.4 Rest of Latin America
• 9.6 Middle East and Africa
  • 9.6.1 Saudi Arabia
  • 9.6.2 South Africa
  • 9.6.3 UAE
  • 9.6.4 Rest of Middle East and Africa

Chapter 10 Company Profiles

• 10.1 Access Vascular, Inc.
• 10.2 AngioDynamic, Inc.
• 10.3 Argon Medical
• 10.4 B. Braun Medical Ltd
• 10.5 Becton, Dickinson and Company
• 10.6 Biowy Corporation
• 10.7 Cardinal Health, Inc.
• 10.8 Footprint Medical Incorporated
• 10.9 ICU Medical, Inc.
• 10.10 Kimal Plc
• 10.11 Medi-Tech Devices
• 10.12 Teleflex Incorporated